icon-    folder.gif   Conference Reports for NATAP  
  20th International AIDS Conference
July 20-25, 2014
Melbourne, Australia
Back grey_arrow_rt.gif
The HCV Care "Cliff": High burden of HCV disease and poor access to HCV services among people who inject drugs in India
  less than 6% are diagnosed, linked to care and treated and much less achieve SVR
Reported by Jules Levin
20th International AIDS Conference, July 20-25, 2014, Melbourne
Sunil S Solomon,1,2 Shruti H Mehta,3 AK Srikrishnan,2 Mark Sulkowski1, Gregory M Lucas,1 CK Vasudevan,2 Allison McFall,3 David D Celentano,3 S Anand,2 Syed H Iqbal,2 Oliver Laeyendecker,1,4 Saravanan S,2 Muniratnam S Kumar,2 Suniti Solomon,2 Thomas C Quinn1,4
1Johns Hopkins University School of Medicine, MD; 2YR Gaitonde Centre for AIDS Research and Education, India; 3Johns Hopkins Bloomberg School of Public Health, USA; 4National Institute of Allergy and Infectious Diseases, MD
from Jules: apparently there is a lacking of an adequate care infrastructure, more centers are needed, improved knowledge among health care providers on HCV treatment is needed as well as an improved laboratory infrastructure availability (HCV antibody testing, HCV RNA, genotyping) to enable efficient HCV treatment delivery